Malaria Genomics, Vaccine Development, and Microbiome

被引:2
|
作者
Su, Xinzhuan [1 ]
Stadler, Rachel V. [1 ]
Xu, Fangzheng [1 ]
Wu, Jian [1 ]
机构
[1] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20892 USA
来源
PATHOGENS | 2023年 / 12卷 / 08期
基金
美国国家卫生研究院;
关键词
Plasmodium; genetics; genotyping; genome diversity; antigen; PLASMODIUM-FALCIPARUM MALARIA; GENETIC DIVERSITY; DRUG-RESISTANCE; MONOCLONAL-ANTIBODIES; PROTECTIVE EFFICACY; ANTIGENIC VARIATION; SELECTIVE SWEEPS; GUT MICROBIOME; SIZE VARIATION; PFSPZ VACCINE;
D O I
10.3390/pathogens12081061
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Recent advances in malaria genetics and genomics have transformed many aspects of malaria research in areas of molecular evolution, epidemiology, transmission, host-parasite interaction, drug resistance, pathogenicity, and vaccine development. Here, in addition to introducing some background information on malaria parasite biology, parasite genetics/genomics, and genotyping methods, we discuss some applications of genetic and genomic approaches in vaccine development and in studying interactions with microbiota. Genetic and genomic data can be used to search for novel vaccine targets, design an effective vaccine strategy, identify protective antigens in a whole-organism vaccine, and evaluate the efficacy of a vaccine. Microbiota has been shown to influence disease outcomes and vaccine efficacy; studying the effects of microbiota in pathogenicity and immunity may provide information for disease control. Malaria genetics and genomics will continue to contribute greatly to many fields of malaria research.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Tomatine as an adjuvant in malaria vaccine development
    Taylor-Robinson, AW
    Morrow, WJW
    DRUGS OF THE FUTURE, 2002, 27 (04) : 391 - 402
  • [32] A new landscape for malaria vaccine development
    Laurenson, Alexander J.
    Laurens, Matthew B.
    PLOS PATHOGENS, 2024, 20 (06)
  • [33] Slow progress in malaria vaccine development
    Alan Dove
    Nature Medicine, 1998, 4 : 479 - 479
  • [34] Malaria Vaccine Development: Challenges and Prospects
    Bharati, Kaushik
    Das, Sunanda
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2019, 13 (08) : AB1 - AB3
  • [35] Virosomal technology in malaria vaccine development
    Pluschke, Gerd
    Tamborrini, Marco
    FUTURE VIROLOGY, 2010, 5 (03) : 247 - 250
  • [36] The development of a multivalent DNA vaccine for malaria
    Richard C. Hedstrom
    Denise L. Doolan
    Ruobing Wang
    Malcolm J. Gardner
    Anita Kumar
    Martha Sedegah
    Robert A. Gramzinski
    John B. Sacci
    Yupin Charoenvit
    Walter R. Weiss
    Michal Margalith
    Jon A. Norman
    Peter Hobart
    Stephen L. Hoffman
    Springer Seminars in Immunopathology, 1997, 19 : 147 - 159
  • [37] LEAPING A HURDLE IN MALARIA VACCINE DEVELOPMENT
    ENGERS, H
    BIO-TECHNOLOGY, 1994, 12 (05): : 461 - 462
  • [38] THE PROMISE OF ASEXUAL MALARIA VACCINE DEVELOPMENT
    PASLOSKE, BL
    HOWARD, RJ
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1994, 50 (04): : 3 - 10
  • [39] Viral vectors in malaria vaccine development
    Limbach, K. J.
    Richie, T. L.
    PARASITE IMMUNOLOGY, 2009, 31 (09) : 501 - 519
  • [40] The immunological challenges of malaria vaccine development
    Wipasa, Jiraprapa
    Riley, Eleanor M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (12) : 1841 - 1852